Arcellx, Inc.

Ownership Transactions Reported by 23 Insiders

Symbol
ACLX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
800 Bridge Parkway, Redwood City, CA

Insiders trading volume in the past year

Arcellx, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gilead Sciences, Inc. 10%+ Owner $371M Dec 28, 2023
NEA Partners 15, L.P. 10%+ Owner $262M Dec 20, 2022
New Enterprise Associates 15, L.P. 10%+ Owner $262M Dec 20, 2022
Holdings A/S Novo 10%+ Owner $222M Feb 8, 2022
Lewis T. Williams Director $116M Feb 8, 2022
Jill Carroll Director $104M May 28, 2024
Sr One Capital Management, Llc 10%+ Owner $91.7M May 11, 2023
Rami Elghandour President, CEO and Chairman of the Board, Director $73M -$7.01M -8.76% Feb 27, 2025
Michelle Gilson Chief Financial Officer $10.2M -$6.11M -37.4% Jan 7, 2025
Christopher Heery Chief Medical Officer $2.43M -$11.1M -82% Feb 24, 2025
Andrew H. Galligan Director $358K Mar 18, 2025
Mohamad Makhzoumi 10%+ Owner $15.6K Dec 20, 2022
Peter W. Sonsini 10%+ Owner $663 Dec 20, 2022
Kavita Patel Director $0 -$8.06M -100% Apr 8, 2025
Olivia C. Ware Director $0 May 28, 2024
David Lubner Director May 28, 2024
Kristin Myers Director Mar 18, 2025
Derek Yoon Director May 28, 2024
Lance E. Thibault Interim Chief Financial Officer Exhibit 24 - Power of Attorney Feb 3, 2022
Ali Behbahani Director May 28, 2024
Anthony A. Florence Jr. 10%+ Owner Dec 20, 2022
Scott D. Sandell 10%+ Owner Dec 23, 2022
Forest Baskett 10%+ Owner Dec 20, 2022

Recent Insider Transactions by Companies or Individuals for Arcellx, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.